The therapeutic effects of 1540-nm nonablative fractional erbium laser on macular amyloidosis: a randomized clinical trial
| Autor: | Azadeh Saki, Bita Kiafar, Yalda Nahidi, Seyedeh Rozita Delghandi |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
medicine.medical_specialty genetic structures Macular amyloidosis Lasers Solid-State Dermatology law.invention 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Humans Medicine Skin 030203 arthritis & rheumatology business.industry Therapeutic effect Skin Diseases Genetic Clinical trial Treatment Outcome Erbium laser Erythema Patient Satisfaction Female business Amyloidosis Familial Erbium |
| Zdroj: | Journal of Dermatological Treatment. 32:340-344 |
| ISSN: | 1471-1753 0954-6634 |
| Popis: | This aim of this study was to determine the effect of 1540-nm nonablative fractional erbium on macular amyloidosis.This phase-II clinical trial study has been performed with parallel group with blinding of the evaluator. The skin lesions of the patients (15 patients and 30 lesions) with cutaneous macular amyloidosis were randomly assigned into laser and no-treatment groups. In the laser group, treatment was performed by 1540-nm nonablative fractional erbium laser. Thereafter, the patients' lesions were compared in terms of pigmentation, rippling, thickness, and subjective response.The lesions of the intervention group significantly improved in the three-month follow-up compared to the control group (in the control and intervention group, improved pigmentation was observed in 20 and 53.3% withUse of 1540-nm nonablative fractional erbium laser offered a suitable efficacy to treat macular amyloidosis without significant complications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|